303 related articles for article (PubMed ID: 18554309)
1. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
[TBL] [Abstract][Full Text] [Related]
2. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
Krentz HB; Kliewer G; Gill MJ
HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
[TBL] [Abstract][Full Text] [Related]
3. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
[TBL] [Abstract][Full Text] [Related]
4. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
Brady MT; Oleske JM; Williams PL; Elgie C; Mofenson LM; Dankner WM; Van Dyke RB;
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):86-94. PubMed ID: 20035164
[TBL] [Abstract][Full Text] [Related]
5. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
6. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.
Mzileni MO; Longo-Mbenza B; Chephe TJ
Pol Arch Med Wewn; 2008 Oct; 118(10):548-54. PubMed ID: 19112815
[TBL] [Abstract][Full Text] [Related]
7. Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.
Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):936-941. PubMed ID: 29901415
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.
Crum NF; Riffenburgh RH; Wegner S; Agan BK; Tasker SA; Spooner KM; Armstrong AW; Fraser S; Wallace MR;
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):194-200. PubMed ID: 16394852
[TBL] [Abstract][Full Text] [Related]
9. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
Smit C; Geskus R; Walker S; Sabin C; Coutinho R; Porter K; Prins M;
AIDS; 2006 Mar; 20(5):741-9. PubMed ID: 16514305
[TBL] [Abstract][Full Text] [Related]
10. Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.
Lee SH; Kim KH; Lee SG; Chen DH; Jung DS; Moon CS; Park JY; Chung JS; Kwak IS; Cho GJ
J Korean Med Sci; 2013 Jan; 28(1):67-73. PubMed ID: 23341714
[TBL] [Abstract][Full Text] [Related]
11. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.
Sabin CA; Smith CJ; Youle M; Lampe FC; Bell DR; Puradiredja D; Lipman MC; Bhagani S; Phillips AN; Johnson MA
AIDS; 2006 Jan; 20(1):67-71. PubMed ID: 16327321
[TBL] [Abstract][Full Text] [Related]
12. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
13. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
[TBL] [Abstract][Full Text] [Related]
14. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.
Bonnet F; Morlat P; Chêne G; Mercié P; Neau D; Chossat I; Decoin M; Djossou F; Beylot J; Dabis F;
HIV Med; 2002 Jul; 3(3):195-9. PubMed ID: 12139658
[TBL] [Abstract][Full Text] [Related]
15. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
16. [Trends in mortality and causes of death among persons with HIV infection, 1985-2004].
Aldaz P; Castilla J; Moreno-Iribas C; Irisarri F; Floristán Y; Sola-Boneta J; Martínez-Artola V; Fernández-Jaúregui C; Dorronsoro I
Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):5-10. PubMed ID: 17261240
[TBL] [Abstract][Full Text] [Related]
17. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
[TBL] [Abstract][Full Text] [Related]
18. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men.
Prins M; Sabin CA; Lee CA; Devereux H; Coutinho RA
AIDS; 2000 Aug; 14(12):1829-37. PubMed ID: 10985321
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.
Nosyk B; Min JE; Evans E; Li L; Liu L; Lima VD; Wood E; Montaner JS
Clin Infect Dis; 2015 Oct; 61(7):1157-65. PubMed ID: 26113656
[TBL] [Abstract][Full Text] [Related]
20. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients.
Antiretroviral Therapy Cohort Collaboration
J Acquir Immune Defic Syndr; 2007 Dec; 46(5):607-15. PubMed ID: 18043315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
